Raymond James & Associates Cara Therapeutics, Inc. Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$9.94 - $12.65 $101,914 - $129,700	-10,253 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$11.99 - $18.14 $155 - $235	-13 Reduced 0.13%	10,253 $125,000
Q3 2021 Nov 02, 2021	SELL	$11.55 - $16.06 $32,340 - $44,968	-2,800 Reduced 21.43%	10,266 $159,000
Q2 2021 Aug 11, 2021	SELL	$12.38 - $29.19 $12,194 - $28,752	-985 Reduced 7.01%	13,066 $186,000
Q1 2021 May 14, 2021	BUY	$15.07 - $21.71 $3,963 - $5,709	263 Added 1.91%	14,051 $305,000

Q4 2020 Feb 12, 2021	BUY	$12.72 - $16.16 $1,615 - $2,052	127 Added 0.93%	13,788 $209,000
Q3 2020 Nov 04, 2020	SELL	$12.34 - $17.92 $9,810 - $14,246	-795 Reduced 5.5%	13,661 $174,000
Q2 2020 Jul 28, 2020	SELL	$12.39 - $17.33 $23,850 - $33,360	-1,925 Reduced 11.75%	14,456 $247,000
Q1 2020 Apr 21, 2020	SELL	$9.12 - $17.78 $45,672 - $89,042	-5,008 Reduced 23.41%	16,381 $216,000
Q4 2019 Feb 12, 2020	SELL	$16.11 - $25.98 $30,544 - $49,258	-1,896 Reduced 8.14%	21,389 $345,000
Q3 2019 Nov 07, 2019	SELL	$18.28 - $26.91 $23,873 - $35,144	-1,306 Reduced 5.31%	23,285 $426,000
Q2 2019 Aug 06, 2019	SELL	$17.68 - $21.57 $80,656 - $98,402	-4,562 Reduced 15.65%	24,591 $529,000
Q1 2019 May 06, 2019	BUY	$14.41 - $19.64 $259,264 - $353,362	17,992 Added 161.2%	29,153 $572,000
Q4 2018 Feb 11, 2019	SELL	$12.45 - $23.47 $28,759 - $54,215	-2,310 Reduced 17.15%	11,161 $145,000
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $7,063 - $9,627	402 Added 3.08%	13,471 $323,000
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $151,600 - $251,839	13,069 New	13,069 $250,000
Q1 2018 May 14, 2018	SELL	$11.77 - $16.08 $191,768 - $261,991	-16,293 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $193,234 - $229,405	16,293 New	16,293 $199,000
Q3 2017 Nov 13, 2017	SELL	$12.6 - $16.34 $141,661 - $183,710	-11,243 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	11,243	11,243 $173,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$889,554
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$645,127
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$471,915
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$442,548
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$404,625
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account